CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Medical Officer sold 7,866 shares at $37.69 ($296,470)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 1,989 shares at an average $37.53 ($74,642)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 30,000 shares at $30.48 ($914,400)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 1,447 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Medical Officer sold 4,007 shares at $37.56 ($150,503)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 2,816 shares (option exercise)
- 4 Option exercise Director acquired 2,816 shares (option exercise)
- 4 Option exercise Director acquired 2,816 shares (option exercise)
- 4 Option exercise Director acquired 2,816 shares (option exercise)
Page 1 of 66 · 1,304 filings